Steven E Come

Steven E Come

UNVERIFIED PROFILE

Are you Steven E Come?   Register this Author

Register author
Steven E Come

Steven E Come

Publications by authors named "Steven E Come"

Are you Steven E Come?   Register this Author

40Publications

915Reads

28Profile Views

Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.

Cancer 2019 Sep 23;125(18):3266-3274. Epub 2019 May 23.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32192
Publisher Site
http://dx.doi.org/10.1002/cncr.32192DOI Listing
September 2019

Anxiety and Depression in Young Women With Metastatic Breast Cancer: A Cross-Sectional Study.

Psychosomatics 2018 May - Jun;59(3):251-258. Epub 2018 Jan 31.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psym.2018.01.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935568PMC
April 2019

Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.

Oncologist 2015 Jul 29;20(7):713-8. Epub 2015 May 29.

Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA; University Hospitals Case Medical Center, Cleveland, Ohio, USA; Harvard Medical School, Boston, Massachusetts, USA; Mayo Clinic, Rochester, Minnesota, USA; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Colorado Cancer Center, Aurora, Colorado, USA; Oregon Health & Science University, Portland, Oregon, USA; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492229PMC
July 2015

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2015 Jun 6;33(17):1902-9. Epub 2015 Apr 6.

Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451173PMC
June 2015

Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2014 Oct 2;32(29):3307-29. Epub 2014 Sep 2.

Ann H. Partridge, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center; Beverly Moy, Massachusetts General Hospital, Boston, MA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA; Angelo Di Leo, Sandro Pitigliani Medical Oncology Unit, Prato, Italy; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Douglas Yee, University of Minnesota/Masonic Cancer Center, Minneapolis, MN; Shelley B. Brundage, Patient Representative, Washington, DC; Maggie Wilcox, Independent Cancer Patients' Voice; and Ian E. Smith, Royal Marsden Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.56.7479
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.7479DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076042PMC
October 2014

Treatment-related amenorrhea and sexual functioning in young breast cancer survivors.

Cancer 2014 Aug 28;120(15):2264-71. Epub 2014 May 28.

Harvard School of Public Health, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28738DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116329PMC
August 2014

Prospective study of fertility concerns and preservation strategies in young women with breast cancer.

J Clin Oncol 2014 Apr 24;32(11):1151-6. Epub 2014 Feb 24.

Kathryn J. Ruddy, Shari I. Gelber, Meghan E. Meyer, and Ann H. Partridge, Dana-Farber Cancer Institute; Rulla M. Tamimi and Elizabeth S. Ginsburg, Brigham and Women's Hospital; Lidia Schapira, Massachusetts General Hospital; Steven E. Come, Beth Israel Deaconess Medical Center, Boston, MA; and Virginia F. Borges, University of Colorado Denver, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.8877DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164759PMC
April 2014

Breast cancer presentation and diagnostic delays in young women.

Cancer 2014 Jan 11;120(1):20-5. Epub 2013 Nov 11.

Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28287DOI Listing
January 2014

Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer.

Expert Opin Drug Saf 2011 Sep 24;10(5):819-26. Epub 2011 Jun 24.

Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, 330 Brookline Ave, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14740338.2011.59
Publisher Site
http://dx.doi.org/10.1517/14740338.2011.595560DOI Listing
September 2011

Review of gene-expression profiling and its clinical use in breast cancer.

Crit Rev Oncol Hematol 2009 Jan 9;69(1):1-11. Epub 2008 Jul 9.

Breast Cancer Program, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2008.05.004DOI Listing
January 2009

Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.

Invest New Drugs 2007 Aug 8;25(4):369-75. Epub 2007 Mar 8.

Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-007-9034-yDOI Listing
August 2007

A 62-year-old woman with a new diagnosis of breast cancer.

Authors:
Steven E Come

JAMA 2006 Mar;295(12):1434-42

Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.295.12.1434DOI Listing
March 2006

Role of fulvestrant in sequential hormonal therapy for advanced, hormone receptor-positive breast cancer in postmenopausal women.

Clin Breast Cancer 2005 Apr;6 Suppl 1:S15-22

Breast Cancer Program, Hematology/Oncology Unit, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
April 2005

Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.

J Clin Oncol 2005 Mar;23(9):1934-40

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.04.032
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.04.032DOI Listing
March 2005

A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.

Cancer 2004 Apr;100(7):1358-64

Department of Radiation Oncology, Brigham and Women's Hospital and the Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20136DOI Listing
April 2004